Par Pharmaceuticals has begun shipment of Modafinil tablets, the generic version of Teva‘s Provigil tablets. Par Pharmaceuticals acquired marketing rights to Modafinil from Teva in connection with Teva’s acquisition of Cephalon.
Provigil is a class CIV narcotic indicated to improve wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome (OSAHS), and shift work sleep disorder (SWSD). Additionally, it is indicated as an adjunct to standard treatment for underlying airway obstruction in OSAHS.
Modafinil tablets are available from Par Pharmaceuticals in 100mg and 200mg dosage strengths in 30- and 90-count bottles.
For more information call (800) 828-9393 or visit www.parpharm.com.